Amgen (AMGN) Tops Q2 EPS by 29c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
Go back to Amgen (AMGN) Tops Q2 EPS by 29c
July 27, 2018 8:48 AM EDT
Baird raised its price target on Amgen (NASDAQ: AMGN) to $179.00 (from $165.00) while maintaining a Neutral rating.
...
More
July 27, 2018 8:24 AM EDT
Cowen raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $204.00) while maintaining a Outperform rating.
Analyst Phil Nadeau commented, "Amgen reported Q2 revenue of $6.06B (+4% Y/Y, vs. consensus of $5.73BE) and non-GAAP EPS of $3.83 (+17% Y/Y, vs. consensus of $3.54E). Amgen both... More
July 27, 2018 7:00 AM EDT
UBS raised its price target on Amgen (NASDAQ: AMGN) to $194.00 (from $180.00) while maintaining a Neutral rating.
...
More
July 27, 2018 6:56 AM EDT
Barclays raised its price target on Amgen (NASDAQ: AMGN) to $195.00 (from $180.00) while maintaining a Equalweight rating following the company's 2Q earnings report.
Amgens portfolio looks poised to deliver flat growth in 2018e, which, in Barclays view, will likely keep... More
July 27, 2018 6:45 AM EDT
Piper Jaffray raised its price target on Amgen (NASDAQ: AMGN) to $210.00 (from $190.00) while maintaining a Overweight rating following the company's 2Q earnings report. AMGN posted Q218 non-GAAP EPS of $3.83, well ahead of consensus $3.55. Upside was operationally driven as revenue beat handily (total revenue was... More
